“Impact of Enhanced Compliance Initiatives on the Efficacy of Rosuvastatin in Reducing Low Density Lipoprotein Cholesterol Levels in Patients With Primary Hypercholesterolaemia”. 2008. Swiss Medical Weekly 138 (2930): 420-26. https://doi.org/10.4414/smw.2008.12120.